Rakos
Attila Rakos, Szekesfehervar HU
Patent application number | Description | Published |
---|---|---|
20130003557 | REDUCING OVERHEAD ON VOICE TRAFFIC - The present invention provides a method, apparatus, gateway and a computer program product for reducing overhead on voice traffic within a packet based communication system. The present invention discloses collecting a plurality of packets to be multiplexed in an aggregated frame, measuring a number of received packets within a predetermined time period, and, if the number of received packets reaches a predetermined value, sending the aggregated frame including the collected packets. | 01-03-2013 |
20130310044 | METHOD AND APPARATUS FOR MANAGING NEIGHBOUR RELATIONS - A method of managing neighbour relations between cells in a cellular communication system comprising the steps of: receiving requests ( | 11-21-2013 |
Karl Rakos, Darlington GB
Patent application number | Description | Published |
---|---|---|
20110081530 | Anti-Microbial Polymeric Film and Method of Manufacture of Said Film - A method of manufacture of an anti-microbial polymeric film comprising coextruding a polymeric substrate layer comprising a first layer of a first polymeric material and a second layer of a second polymeric material wherein the crystalline melting temperature (TM | 04-07-2011 |
20110209901 | COATED POLYESTER FILM - A method of improving the flexibility of a coated polyester substrate for an electronic device comprising a coated polyester substrate layer and an electrode layer comprising conductive material, said method comprising: (a) providing a polyester film; and (b) disposing an organic/inorganic hybrid coating on one or both surfaces of said polyester film, wherein said coating is derived from a coating composition comprising a low molecular weight reactive component selected from monomeric acrylates and/or an unsaturated oligomeric component selected from acrylates, polyether acrylates, epoxy acrylates and polyester acrylates; a solvent; and inorganic particles, and optionally further comprising a photoinitiator. | 09-01-2011 |
20140008026 | Film Comprising a Strippable Sacrificial Layer for Reduction of Surface Defects in a Substrate - A coextruded biaxially oriented composite film comprising a polyester substrate layer and disposed on one or both surfaces thereof a strippable sacrificial layer, wherein said strippable sacrificial layer comprises an ethylene-methacrylic acid (EMAA) copolymer. | 01-09-2014 |
Karl Rakos, Durham GB
Patent application number | Description | Published |
---|---|---|
20100154886 | COATED POLYMERIC SUBSTRATES HAVING IMPROVED SURFACE SMOOTHNESS SUITABLE FOR USE IN FLEXIBLE ELECTRONIC AND OPTO-ELECTRONIC DEVICES - The use of a coating composition comprising: | 06-24-2010 |
20100159198 | COATED POLYMERIC SUBSTRATES HAVING IMPROVED SURFACE SMOOTHNESS SUITABLE FOR USE IN FLEXIBLE ELECTRONIC AND OPTO-ELECTRONIC DEVICES - The use of a coating composition comprising: | 06-24-2010 |
Laszlo Rakos, Macclesfield UK
Patent application number | Description | Published |
---|---|---|
20130210837 | Compounds and Their Use as BACE Inhibitors - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 08-15-2013 |
Laszlo Rakos, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20150133471 | COMPOUNDS AND THEIR USE AS BACE INHIBITORS - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 05-14-2015 |
Laszlo Rakos, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20100003216 | HCV NS-3 Serine Protease Inhibitors - Compounds of the formula | 01-07-2010 |
Laszlo Rakos, Södertalje SE
Patent application number | Description | Published |
---|---|---|
20100292210 | Novel Compounds for A-Beta-Related Pathologies - The present invention relates to novel compounds of formulae I and II and therapeutically acceptable salts thereof, their pharmaceutical compositions processes for making them and their use in therapeutic methods for treatment and/or prevention of various diseases. In particular, the invention relates to compounds which interfere with γ-secretase and/or its substrate and hence modulate the formation of Aβ peptides. | 11-18-2010 |
Laszlo Rakos, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20130345247 | Cyclohexane-1,2'-Indene-1',2"-Imidazol Compounds and Their Use as Bace Inhibitors - Cyclohexane-1,2′-indene-1′,2″-imidazole compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration, methods of therapy using such compounds, and pharmaceutical compositions containing such compounds. | 12-26-2013 |
20130345272 | Cycloalkyl Ether Compounds and Their Use as Bace Inhibitors - Cycloalkyl ether compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration and pharmaceutical compositions containing such compounds. | 12-26-2013 |
Ronald Rakos, Neshanic Station, NJ US
Patent application number | Description | Published |
---|---|---|
20100137969 | Composite Medical Textile Material and Implantable Devices Made Therefrom - An implantable composite medical device having a longitudinal length a woven textile portion having yarns interlaced in a woven pattern, a knitted textile portion having yarns interlooped in a knitted pattern. The woven and knitted portions are securably attached to one and the other to provide a composite woven and knitted textile surface along the longitudinal length of the device. The woven portion may have a permeability from about 30 to about 500 ml/min/cm | 06-03-2010 |
20100288421 | IMPLANTABLE PROSTHESIS HAVING REINFORCED ATTACHMENT SITES - The present invention provides an implantable graft that includes an elongate graft tube having opposing ends defining an attachment site for attaching the graft to a stent. The graft further includes a reinforcement member attached adjacent to at least one of the ends of the graft for establishing a reinforced attachment site for the graft, thereby preventing elongation of a suture hole in the material. Furthermore, the present invention provides a graft wherein at least one end of the graft is folded over itself and glued or sutured to itself and/or the stent, thereby forming a reinforcement thereto. | 11-18-2010 |
20110238158 | EXPANDABLE VASCULAR ENDOLUMINAL PROSTHESES - The invention provides expandable tubular endoluminal prostheses for the treatment of atherosclerotic lesions of blood vessels, including vulnerable plaque lesions, and methods of treatment using the prostheses. Various prostheses of the invention are characterized by hoop strength suitable for treating vulnerable plaque lesions, good conformability and good apposition to vessel walls, as well as minimal coverage areas in order to minimize the inflammatory response to the implanted prostheses. | 09-29-2011 |
20130095264 | Composite ePTFE/Textile Prosthesis - A composite intraluminal prosthesis which is preferably used as a vascular prothesis includes a layer of ePTFE and a layer of textile material which are secured together by an elastomeric bonding agent. The ePTFE layer includes a porous microstructure defined by nodes interconnected by fibrils. The adhesive bonding agent is preferably applied in solution so that the bonding agent enters the pores of the microstructure of the ePTFE. This helps secure the textile layer to the ePTFE layer. | 04-18-2013 |
20130116768 | Composite Medical Textile Material and Implantable Devices Made Therefrom - An implantable composite medical device having a longitudinal length a woven textile portion having yarns interlaced in a woven pattern, a knitted textile portion having yarns interlooped in a knitted pattern. The woven and knitted portions are securably attached to one and the other to provide a composite woven and knitted textile surface along the longitudinal length of the device. The woven portion may have a permeability from about 30 to about 500 ml/min/cm | 05-09-2013 |
Ronald Rakos, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20080317827 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels - Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel. | 12-25-2008 |
20100239636 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels - Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel. | 09-23-2010 |
20120172976 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels - The present disclosure pertains to stents having a coating applied thereto, wherein the coating comprises a biocompatible polymer/drug mixture, as well as devices comprising a metallic stent, a biocompatible polymeric carrier and a drug. | 07-05-2012 |
20140303717 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels - The present disclosure pertains to stents having a coating applied thereto, wherein the coating comprises a biocompatible polymer/drug mixture, as well as devices comprising a metallic stent, a biocompatible polymeric carrier and a drug. | 10-09-2014 |